European Countries Focus Horizon Scanning On Alzheimer’s Disease
BeNeLuxA Pre-Empts Access Challenges For Alzheimer's Disease
Executive Summary
Working out what’s on the horizon in terms of potential new treatments for Alzheimer’s disease should help countries prepare for the challenges that will be involved when it comes to determining patient access.
You may also be interested in...
Gene Therapy Libmeldy Undergoes Cross-Country HTA In Europe
Cross-country drug access coalition BeNeLuxA is reviewing the costly one-off gene therapy for children with metachromatic leukodystrophy.
Novel Sickle Cell Treatment Among 13 New Drugs On Track For EU Approval
A first-of-its-kind drug for uterine fibroids and a new monoclonal antibody treatment for COVID-19 are among several new drugs recommended for pan-EU approval this month.
Brazilian Regulator Consults On Improving Rules For Registering Biosimilars
ANVISA, Brazil’s medicines regulator, is asking for feedback on the regulatory pathway for biosimilars.